CLDX vs. UFPT
CLDX (Celldex Therapeutics, Inc.) and UFPT (UFP Technologies, Inc.) are both stocks. Both are in the Healthcare sector — CLDX in Biotechnology, UFPT in Medical Devices. Over the past 10 years, CLDX returned -6.50%/yr vs 27.21%/yr for UFPT. At a 0.21 correlation, their price movements are largely independent.
Performance
CLDX vs. UFPT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLDX achieves a 23.01% return, which is significantly higher than UFPT's 5.08% return. Over the past 10 years, CLDX has underperformed UFPT with an annualized return of -6.50%, while UFPT has yielded a comparatively higher 27.21% annualized return.
CLDX
- 1D
- 3.02%
- 1M
- 8.72%
- YTD
- 23.01%
- 6M
- 22.52%
- 1Y
- 62.98%
- 3Y*
- -1.99%
- 5Y*
- 2.17%
- 10Y*
- -6.50%
UFPT
- 1D
- -2.50%
- 1M
- 1.89%
- YTD
- 5.08%
- 6M
- 1.58%
- 1Y
- -0.59%
- 3Y*
- 6.87%
- 5Y*
- 31.89%
- 10Y*
- 27.21%
CLDX vs. UFPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLDX Celldex Therapeutics, Inc. | 23.01% | 7.48% | -36.28% | -11.02% | 15.35% | 120.55% | 685.65% | -24.88% | -93.03% | -19.77% |
UFPT UFP Technologies, Inc. | 5.08% | -9.19% | 42.12% | 45.93% | 67.79% | 50.77% | -6.07% | 65.15% | 8.06% | 9.23% |
Correlation
The correlation between CLDX and UFPT is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Mar 10, 2008 | 0.21 |
Fundamentals
CLDX:
$2.22B
UFPT:
$1.82B
CLDX:
-$4.27
UFPT:
$8.81
CLDX:
2.71K
UFPT:
2.98
CLDX:
4.87
UFPT:
4.15
CLDX:
$820.00K
UFPT:
$608.85M
CLDX:
$805.00K
UFPT:
$172.62M
CLDX:
-$216.32M
UFPT:
$111.39M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLDX vs. UFPT — Risk / Return Rank
CLDX
UFPT
CLDX vs. UFPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and UFP Technologies, Inc. (UFPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLDX | UFPT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.13 | ||
| Sortino ratioReturn per unit of downside risk | +1.66 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.04 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.61 | -0.02 | +2.63 |
| Martin ratioReturn relative to average drawdown | 6.76 | -0.03 | +6.79 |
Loading charts...
Drawdowns
CLDX vs. UFPT - Drawdown Comparison
The maximum CLDX drawdown since its inception was -99.73%, which is greater than UFPT's maximum drawdown of -88.53%. Use the drawdown chart below to compare losses from any high point for CLDX and UFPT.
Loading charts...
Drawdown Indicators
| CLDX | UFPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.73% | -88.53% | -11.20% |
Max Drawdown (1Y)Largest decline over 1 year | -24.23% | -30.69% | +6.46% |
Max Drawdown (3Y)Largest decline over 3 years | -70.84% | -48.31% | -22.53% |
Max Drawdown (5Y)Largest decline over 5 years | -73.11% | -48.31% | -24.80% |
Max Drawdown (10Y)Largest decline over 10 years | -97.90% | -48.31% | -49.59% |
Current DrawdownCurrent decline from peak | -94.11% | -34.91% | -59.20% |
Average DrawdownAverage peak-to-trough decline | -78.04% | -32.24% | -45.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.35% | 16.94% | -7.59% |
Volatility
CLDX vs. UFPT - Volatility Comparison
Celldex Therapeutics, Inc. (CLDX) has a higher volatility of 11.62% compared to UFP Technologies, Inc. (UFPT) at 8.94%. This indicates that CLDX's price experiences larger fluctuations and is considered to be riskier than UFPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLDX | UFPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.62% | 8.94% | +2.68% |
Volatility (6M)Calculated over the trailing 6-month period | 38.03% | 30.66% | +7.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.82% | 43.80% | +13.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.21% | 44.31% | +14.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.95% | 39.59% | +38.36% |
Dividends
CLDX vs. UFPT - Dividend Comparison
Neither CLDX nor UFPT has paid dividends to shareholders.
Financials
CLDX vs. UFPT - Financials Comparison
This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and UFP Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLDX and UFPT have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLDX has higher volatility (11.62%) compared to UFPT (8.94%). In terms of maximum drawdown, CLDX dropped -99.73% vs UFPT's -88.53%.
CLDX currently has the higher Sharpe Ratio (1.12 vs -0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLDX and UFPT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer